ESPRIVIIM Trademark

Trademark Overview

On Wednesday, May 23, 2007, a trademark application was filed for ESPRIVIIM with the United States Patent and Trademark Office. The USPTO has given the ESPRIVIIM trademark a serial number of 79040339. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, May 23, 2017. This trademark is owned by Merck KGaA. The ESPRIVIIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer
espriviim

General Information

Serial Number79040339
Word MarkESPRIVIIM
Filing DateWednesday, May 23, 2007
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, May 23, 2017
Registration Number3392193
Registration DateTuesday, March 4, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 18, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 10, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, December 22, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, December 22, 2017DEATH OF INTERNATIONAL REGISTRATION
Friday, August 28, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, August 13, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, August 13, 2015INVALIDATION PROCESSED
Wednesday, June 10, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 10, 2014CANCELLED SECTION 71
Thursday, April 30, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, June 11, 2008FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, June 11, 2008FINAL DISPOSITION PROCESSED
Wednesday, June 4, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 4, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, December 18, 2007PUBLISHED FOR OPPOSITION
Wednesday, November 28, 2007NOTICE OF PUBLICATION
Saturday, November 10, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, November 10, 2007ASSIGNED TO LIE
Tuesday, October 9, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 4, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 4, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 4, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 4, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 29, 2007REFUSAL PROCESSED BY IB
Wednesday, September 12, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 6, 2007REFUSAL PROCESSED BY MPU
Thursday, September 6, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 5, 2007NON-FINAL ACTION WRITTEN
Wednesday, September 5, 2007ASSIGNED TO EXAMINER
Friday, August 10, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, August 9, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

espriviim cancer treatment prevention preparations pharmaceutical